Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

NCT01525407 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm

Interventions

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Atorvastatin Calcium
PROCEDURE: Peripheral Blood Stem Cell Transplantation

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]